Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,973.5
49.0 (1.67%)

 

  • STI Straits Times Index
    2,973.5
    49.0 (1.67%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,581.5
    24.0 (1.54%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    30,074.2
    355.9 (1.20%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,585.0
    21.0 (0.59%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,671.7
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,289.6
    38.6 (0.62%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,898.3M
  • Value: 1,929.3M
  • Rise: 245
  • Fall: 121
  • Unch: 410

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Thomson Medical0.119+0.010
Shen Yao0.004-
Oceanus^0.075+0.004
Secura0.103+0.017
Jiutian Chemical0.095-0.001
Sembcorp Marine0.155+0.003
ThaiBev0.735+0.015
YZJ Shipbldg SGD1.060+0.020
Singtel2.380-
SIA5.030+0.340

World Indices

World Indices
Name Last Change
Nasdaq 13,598.0 +132.8
HSI 30,074.2 +355.9
HSCEI 11,717.4 +207.7
Jakarta 6,289.6 +38.6
Nikkei 225 29,671.7
SSE Comp 3,585.0 +21.0
Shanghai A 3,758.0 +22.0
Shanghai B 245.9
KOSPI 3,099.7 +104.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Annica ANNICA HOLDINGS LIMITED
Quotes 10 Minutes Delayed. Updated at 25 Feb 2021 16:42
Last (SGD): 0.001 Change: - High: 0.001 Remarks: -
Change (%): - Low: 0.001
Open 0.001 Yesterday's Close 0.001
Buy Price - Sell Price 0.001
Buy Volume ('000) - Sell Volume ('000) 1,096,507.7
Cumulative Volume ('000) 130.0 Cumulative Value 130
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.00003 Trailing EPS (SGD) e -0.00004 NAV (SGD) b 0.0002
PE a - Trailing PE f - Price / NAV b 5.0000
Dividend (SGD) d - Cash In Hand (SGD) g 0.0001 Issued & Paid-up Shares c 16,674,767,000
Dividend Yield (%) d - Price / Cash In Hand g 10.000 Treasury Shares h -
Beta - 75 Daysi - R-Squared - 75 Days(%)i - Market Cap (M) 16.675
Beta - 500 Daysi - R-Squared - 500 Days (%)i - Enterprise Value (M) 15.753
Piotroski F Score 3 Exchange Code 5AL Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 0.0 6-Month VWAP 0.001 Free Float (%) -
Under CPF Investment Scheme (CPFIS) Yes
Sector & Industry Manufacturing - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Annica SGX 16.675 - - 5.0000 -
Industry Medical Specialties SGX 2,561.528 25.055 10.469 7.1417 2.046
Local Peer Top Glove SGX 14,241.773 23.458 10.539 7.8242 2.199
Local Peer Medtecs Intl SGX 609.846 389.474 11.043 4.3174 -
Local Peer UGHealthcare SGX 406.731 30.345 6.026 3.2023 0.344
Local Peer Biolidics SGX 77.894 - - 7.2304 -
Local Peer Yunnan Energy SGX 16.251 - - 0.3360 -
Global Peer ABBOTT LABORATORIES NYSE 216,799.841 48.468 48.469 6.6130 1.250
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 180,990.341 28.391 28.391 5.2450 -
Global Peer MEDTRONIC PLC NYSE 159,998.588 33.410 45.236 - 1.878
Global Peer DANAHER CORP NYSE 158,553.000 45.172 45.172 4.3442 0.323
Global Peer STRYKER CORP NYSE 93,606.333 58.541 58.541 7.1543 0.946
Global Peer INTUITIVE SURGICAL INC NASDAQ 89,313.824 84.211 84.211 9.1778 -
Global Peer BECTON DICKINSON & CO NYSE 71,684.058 93.460 47.536 2.9068 1.295
Global Peer BOSTON SCIENTIFIC CORP NYSE 56,020.730 - - - -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 52,740.630 64.052 64.052 11.5298 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 51,013.014 37.700 37.946 3.5124 1.833
Other Global Peers IDEXX LABORATORIES INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), HOLOGIC INC (NASDAQ), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), BIO RAD LABORATORIES INC (NYSE), NOVOCURE LTD (NASDAQ), WATERS CORP (NYSE), INSULET CORPORATION (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), STERIS PLC (NYSE), ABIOMED INC (NASDAQ), PERKINELMER INC (NYSE), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), QIAGEN NV (NYSE), MICROPORT (HKEx), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), TOPGLOV (Bursa), BRUKER CORPORATION (NASDAQ), HARTA (Bursa), WEIGAO GROUP (HKEx), SOTERA HEALTH CO (NASDAQ), QUIDEL CORP (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEVRO CORP (NYSE), TANDEM DIABETES CARE INC (NASDAQ), CARDIOFLOW-B (HKEx), STAAR SURGICAL CO (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), GLAUKOS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), BUTTERFLY NETWORK INC (NYSE), VENUS MEDTECH-B (HKEx), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), CAREDX INC (NASDAQ), CONMED CORP (NYSE), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), CANTEL MEDICAL CORP (NYSE), SUPERMX (Bursa), NUVASIVE INC (NASDAQ), ATRICURE INC (NASDAQ), INMODE LTD (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), EARGO INC (NASDAQ), LIFETECH SCI (HKEx), VERICEL CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), OUTSET MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), PEIJIA-B (HKEx), PULMONX CORPORATION (NASDAQ), HESKA CORP (NASDAQ), KANGJI MEDICAL (HKEx), DERMTECH INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), AK MEDICAL (HKEx), ESTABLISHMENT LABS HLDGS INC (NASDAQ), 908 DEVICES INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), NANOSONICS LIMITED (ASX), LANTHEUS HOLDINGS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), INOGEN INC (NASDAQ), CERUS CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SI BONE INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CRYOLIFE INC (NYSE), BASECARE-B (HKEx), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CHUNLI MEDICAL (HKEx), AXOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), KDL MEDICAL (HKEx), LUCIRA HEALTH INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ANGIODYNAMICS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), BIOVENTUS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), VIEWRAY INC (NASDAQ), SURMODICS INC (NASDAQ), VAPOTHERM INC (NYSE), ACCELERATE DIAGNOSTICS INC (NASDAQ), CUTERA INC (NASDAQ), ZYNEX INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), CORMEDIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ACCURAY INCORPORATED (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), CLEANSPACE HOLDINGS LTD (ASX), SIENTRA INC (NASDAQ), NEURONETICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), STEREOTAXIS INC (NYSE American), APYX MEDICAL CORPORATION (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), YESTAR HEALTH (HKEx), PAVMED INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), INVACARE CORP (NYSE), UTAH MEDICAL PRODUCTS (NASDAQ), MISONIX INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), AROA BIOSURGERY LTD (ASX), SOLITON INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), IRADIMED CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), ALPHA PRO TECH (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), CONFORMIS INC (NASDAQ), CYCLOPHARM LIMITED (ASX), ONCOCYTE CORP (NYSE American), REPRO MEDSYSTEMS INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERN DENTAL (HKEx), NEMAURA MEDICAL INC (NASDAQ), AVINGER INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), BIOLASE INC (NASDAQ), KELFRED (HKEx), CELSION CORPORATION (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), VINCENT MED (HKEx), MICRO-X LTD (ASX), FONAR CORP (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), EMVISION MEDICAL DEVICES LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), PW MEDTECH (HKEx), IMPEDIMED LIMITED (ASX), SOMNOMED LIMITED (ASX), VOLITIONRX LIMITED (NYSE American), LIANLUO SMART LIMITED (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), OPTISCAN IMAGING (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROCORE INC (NASDAQ), NEOVASC INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), LENSAR INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), IRIDEX CORP (NASDAQ), ELECTROMED INC (NYSE American), IMMUCELL CORP (NASDAQ), NEPHROS INC (NASDAQ), RESPIRI LTD (ASX), RESONANCE HEALTH LTD (ASX), BIOMERICA INC (NASDAQ), SDI LTD (ASX), RGTBHD (Bursa), APPLIED UV INC (NASDAQ), YUNNAN ENERGY (HKEx), LKL (Bursa), CHECK-CAP LTD (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), COMPUMEDICS (ASX), CARDIEX LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), DAXOR CORP (NYSE American), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), XTANT MEDICAL HLDGS INC (NYSE American), RESAPP HEALTH LIMITED (ASX), TENAX THERAPEUTICS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), OBALON THERAPEUTICS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), OVENTUS MEDICAL LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ), LIFE HEALTHCARE (HKEx), RA MEDICAL SYSTEMS INC (NYSE American), CHF SOLUTIONS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), USCOM LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), METALICITY LIMITED (ASX), NEUROMETRIX INC (NASDAQ), ADHERIUM LIMITED (ASX), DORSAVI LTD (ASX), ANALYTICA (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

Not enough data to show total shareholder returns
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.001 - 0.001 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High - % Change From 1 Year High (%) -
2 Years Range 0.001 - 0.001 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High - % Change From 2 Years High (%) -
5 Years Range 0.001 - 0.002 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.001 % Change From 5 Years High (%) -50.00
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company was incorporated in Singapore on 20 August 1983 and admitted to the Catalist Board of the SGX-ST in 2001, it is an investment holding company with subsidiaries operating mainly in Singapore, Malaysia, Indonesia and Brunei, trading in oilfield equipment & related products, designing of industrial plant & rendering of engineering services, an integrated solutions provider for renewable sector and investment holding.

IPO Performance

Listing Date 11 Apr 2001 Full Subscription Rate (x) 1.03
No of Placement Shares (M) 19.76 No of Public Offer Shares (M) 2.20 Public Offer Subscription Rate (x) 1.29
IPO Price (SGD) a 0.193 First Day Close (SGD) a 0.160 First Week Close (SGD) a 0.168
Current vs IPO Price (%) -99.48 First Day Gain (%) -17.10 First Week Gain (%) -12.95
Notes:
  1. Adjusted for the following: Rights Issue 1 for 1 @ $0.015 on 14/12/2012

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(2.63 MB)
Part 2(0.01 MB)
Annual Report 2018 Dec 2018 Part 1(0.34 MB)
Part 2(4.40 MB)
Annual Report 2017 Dec 2017 Part 1(0.03 MB)
Part 2(0.31 MB)
Part 3(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(0.53 MB)
Annual Report 2015 Dec 2015 Part 1(1.96 MB)
Annual Report 2014 Dec 2014 Part 1(0.78 MB)
Annual Report 2013 Dec 2013 Part 1(0.61 MB)
Annual Report 2012 Dec 2012 Part 1(0.33 MB)
Annual Report 2011 Dec 2011 Part 1(0.28 MB)
Annual Report 2010 Dec 2010 Part 1(1.97 MB)
Annual Report 2009 Dec 2009 Part 1(0.02 MB)
Part 2(0.37 MB)
Annual Report 2008 Dec 2008 Part 1(0.45 MB)
Annual Report 2007 Dec 2007 Part 1(0.70 MB)
Annual Report 2006 Dec 2006 Part 1(1.12 MB)
Annual Report 2005 Dec 2005 Part 1(6.97 MB)
IPO Prospectus
IPO Prospectus 2001 Mar 2001 Part 1(2.58 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
25 Feb 2021 0.001 0.001 0.001 0.001 130,000 0.0010
24 Feb 2021 0.001 0.001 0.001 0.001 5,000,000 0.0010
23 Feb 2021 0.001 0.001 0.001 0.001 38,600,000 0.0010
22 Feb 2021 0.001 0.001 0.001 0.001 32,035,000 0.0010
19 Feb 2021 0.001 0.001 0.001 0.001 1,900,000 0.0010
18 Feb 2021 0.001 0.001 0.001 0.001 100 0.0010
17 Feb 2021 0.001 0.001 0.001 0.001 - -
16 Feb 2021 0.001 0.001 0.001 0.001 - -
15 Feb 2021 0.001 0.001 0.001 0.001 212,100 0.0010
11 Feb 2021 0.001 0.001 0.001 0.001 - -
10 Feb 2021 0.001 0.001 0.001 0.001 - -
09 Feb 2021 0.001 0.001 0.001 0.001 - -
08 Feb 2021 0.001 0.001 0.001 0.001 - -
05 Feb 2021 0.001 0.001 0.001 0.001 5,000,000 0.0010
04 Feb 2021 0.001 0.001 0.001 0.001 - -
03 Feb 2021 0.001 0.001 0.001 0.001 100 0.0010
02 Feb 2021 0.001 0.001 0.001 0.001 100,000 0.0010
01 Feb 2021 0.001 0.001 0.001 0.001 1,390,000 0.0010
29 Jan 2021 0.001 0.001 0.001 0.001 - -
28 Jan 2021 0.001 0.001 0.001 0.001 - -
27 Jan 2021 0.001 0.001 0.001 0.001 2,601,100 0.0010
26 Jan 2021 0.001 0.001 0.001 0.001 756,900 0.0010
Summary
Current 2 Weeks
(11 Feb 2021 to 25 Feb 2021)
0.001 0.001 0.001 0.001 77,877,200 -
Previous 2 Weeks
(28 Jan 2021 to 10 Feb 2021)
0.001 0.001 0.001 0.001 6,490,100 -
4 Weeks from
(30 Dec 2020 to 27 Jan 2021)
0.001 0.001 0.001 0.001 271,525,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.